Implantable Defibrillator User
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BiotronikPlexa ICD Lead Registry
AbbottEllipse VR ICD and Durata/Optisure lead
BiotronikProtego DF4 Post Approval Registry
Clinical Trials (3)
Total enrollment: 2,822 patients across 3 trials
Plexa ICD Lead Registry
Start: May 2017Est. completion: Sep 2019901 patients
N/ATerminated
A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study
Start: May 2016Est. completion: Apr 2018227 patients
N/ACompleted
Protego DF4 Post Approval Registry
Start: Sep 2014Est. completion: Apr 20191,694 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space